Clinical Trial Update: Combination of Ranibizumab and Targeted Laser Photocoagulation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the combination of ranibizumab with targeted laser photocoagulation for central retinal vein occlusion with macular edema is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion with Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Giessen | Conditions: Central Retinal Vein Occlusion With Macular Edema | Phase 3 | Status: RECRUITING